Postoperative ventilatory and circulatory effects of extended rewarming during cardiopulmonary bypass

Optimal Conditions for Cardiopulmonary Bypass

There is no single optimal set of conditions for cardio pulmonary bypass. What is optimal is determined by patient factors, surgical need, and the mechanics of perfusion. Additionally, the best way to manage bypass typically varies over its course.

Efficacy of forced-air warming systems with full body blankets

PURPOSE

Postoperative hypothermia after cardiac surgery is still a common problem often treated with forced-air warming. This study was conducted to determine the heat transfer efficacy of 11 forced-air warming systems with full body blankets on a validated copper manikin.

METHODS

The following systems were tested: 1) Bair Hugger 505; 2) Bair Hugger 750; 3) Life-Air 1000 S; 4) Snuggle Warm; 5) Thermacare; 6) Thermacare with reusable Optisan blanket; 7) WarmAir; 8) Warm-Gard; 9) Warm-Gard and reusable blanket; 10) WarmTouch; and 11) WarmTouch and reusable blanket. Heat transfer of forced-air warmers can be described as follows: Q = h x DeltaT x A. Where Q = heat flux (W), h = heat exchange coefficient (W x m-2 x degrees C-1), DeltaT = temperature gradient between blanket and manikin surface (degrees C), A = covered area (m2). Heat flux per unit area and surface temperature were measured with 16 heat flux transducers. Blanket temperature was measured using 16 thermocouples. The temperature gradient between blanket and surface (DeltaT) was varied and h was determined by linear regression analysis. Mean DeltaT was determined for surface temperatures between 32 degrees C and 38 degrees C. The covered area was estimated to be 1.21 m2.

RESULTS

For the 11 devices, heat transfers of 30.7 W to 77.3 W were observed for surface temperatures of 32 degrees C, and between -8.8 W to 29.6 W for surface temperatures of 38 degrees C.

CONCLUSION

There are clinically relevant differences between the tested forced-air warming systems with full body blankets. Several systems were unable to transfer heat to the manikin at a surface temperature of 38 degrees C.

Postanaesthetic shivering: epidemiology, pathophysiology, and approaches to prevention and management

Along with nausea and vomiting, postanaesthetic shivering is one of the leading causes of discomfort for patients recovering from general anaesthesia. The distinguishing factor during electromyogram recordings between patients with postanaesthetic shivering and shivering in fully awake patients is the existence of clonus similar to that recorded in patients with spinal cord transection. Clonus coexists with the classic waxing and waning signals associated with cutaneous vasoconstriction (thermoregulatory shivering). The primary cause of postanaesthetic shivering is peroperative hypothermia, which sets in because of anaesthetic-induced inhibition of thermoregulation. However, shivering associated with cutaneous vasodilatation (non-thermoregulatory shivering) also occurs, one of the origins of which is postoperative pain. Apart from causing discomfort and aggravation of pain, postanaesthetic shivering increases metabolic demand proportionally to the solicited muscle mass and the cardiac capacity of the patient. No link has been demonstrated between the occurrence of shivering and an increase in cardiac morbidity, but it is preferable to avoid postanaesthetic shivering because it is oxygen draining. Prevention mainly entails preventing peroperative hypothermia by actively rewarming the patient. Postoperative skin surface rewarming is a rapid way of obtaining the threshold shivering temperature while raising the skin temperature and improving the comfort of the patient. However, it is less efficient than certain drugs such as meperidine, clonidine or tramadol, which act by reducing the shivering threshold temperature.

Oxygen consumption after hypothermic cardiopulmonary bypass: the effect of continuing a propofol infusion postoperatively

OBJECTIVE

To evaluate the effect of a fixed rate of infusion of propofol on total body oxygen consumption during the postoperative rewarming phase after cardiopulmonary bypass.

DESIGN

Prospective, randomized, controlled study.

SETTING

Cardiac intensive care unit, university hospital.

PARTICIPANTS

Twenty-four male and female patients undergoing elective first-time coronary artery bypass graft surgery.

INTERVENTIONS

Total body oxygen consumption was measured using a pulmonary artery catheter and thermodilution during postoperative rewarming. Twelve patients had propofol infused at 2 mg/kg/h for 4 hours or until rewarmed.

MEASUREMENTS AND MAIN RESULTS

Total body oxygen consumption was reduced in the propofol group compared with the control group. Oxygen consumption was a median of 30.0 mL/min/m(2) less in the patients receiving propofol (p = 0.01). One patient receiving propofol shivered compared with 4 in the control group (p = 0.14).

CONCLUSION

Administration of propofol during postoperative rewarming reduces total body oxygen consumption and may reduce shivering.

Cerebral hyperthermia and cardiac surgery: consequences and prevention

Temperature management during cardiac surgery deserves considerable attention because it has broad effects, altering virtually every physiologic process, including oxygen demand, blood flow, cardiac output, and coagulation. Temperature is also important in cardiac surgery because virtually all patients undergo significant temperature change. These changes can be unique in mammalian physiology both with regard to their magnitude and rate of change. Furthermore, cardiac surgical patients may be uniquely vulnerable to the effects of temperature. Because of vascular disease and embolization, many patients are at risk for cerebral ischemia. Additionally, their cardiac, pulmonary, and renal reserve is typically limited; and there is risk for perioperative bleeding. Patient temperature can affect all of these processes and has its greatest effect on those who are physiologically most fragile. An appreciation for temperature management is also compelling because, unlike new technologies, procedures, or drugs; temperature management is simple, practical, applicable to every patient, and can be performed with very little cost. This article will show why cerebral hyperthermia should be avoided in cardiac surgery. Second, it will discuss why it occurs and the management steps that may prevent it. Finally, we will highlight recent discussion of postoperative hyperthermia and speculate as to its origin and relevance.

Oxygen consumption after cardiopulmonary bypass surgery in children: determinants and implications

OBJECTIVE

We sought to assess oxygen consumption and its determinants in children shortly after undergoing cardiopulmonary bypass operations.

METHODS

Twenty children, aged 2 months to 15 years (median, 3.75 years), undergoing hypothermic cardiopulmonary bypass operations were studied during the first 4 hours after arrival in the intensive care unit. Central and peripheral temperatures were monitored. Oxygen consumption was continuously measured by using respiratory mass spectrometry. Oxygen delivery was calculated from oxygen consumption and arterial and mixed venous oxygen contents, which were sampled every 30 minutes. Oxygen extraction was derived by the ratio of oxygen consumption and oxygen delivery. Arterial blood lactate levels were measured every 30 minutes.

RESULTS

There was a correlation between oxygen consumption and age in patients older than 3 months (r = -0.76). Mean oxygen consumption increased by 14.7% during the study. The increase in oxygen consumption was correlated with the increase in central temperature (r = 0.73). Nine patients had an arterial lactate level above 2 mmol/L on arrival. There were no significant differences in oxygen consumption, oxygen delivery, and oxygen extraction between the group with lactate levels between 2 and 3 mmol/L and the groups with normal lactate levels both on arrival and at 2 hours. One patient with a peak lactate level of 6.8 mmol/L had initially low oxygen delivery (241.3 mL. min(-1). m(-2)).

CONCLUSIONS

During the early hours after a pediatric cardiac operation, the increase in oxygen consumption is mainly attributed to the increase in central temperature. Oxygen consumption is negatively related to age. Mild lactatemia is common and does not appear to reflect oxygen delivery or oxygen consumption or a more complicated recovery.

Convective warming blankets improve peroperative heat preservation in congenital heart surgery

Peroperative heat preservation, following hypothermic cardiopulmonary bypass (CPB) in children, has always been a challenge to the anaesthetist. We studied the efficiency of a convective heating system on peroperative heat preservation in 50 children undergoing congenital heart surgery. Twenty-five children, rewarmed by CPB and heating mattress, were randomly selected (Group 1). Another 25 children, rewarmed by CPB, heating mattress and convective warming blankets in addition (Group 2), were selected so the two groups were comparable regarding age, weight and anaesthetic management. The central and peripheral temperatures were measured during bypass, at the end of bypass and at the end of operation. A retrospective evaluation showed that during bypass the peripheral temperature was significantly lower in Group 2 than in Group 1, with no significant difference in central temperature. At the end of bypass there was no significant difference between the two groups. At the end of operation the central and peripheral temperatures were significantly higher in Group 2. In conclusion convective warming blankets are effective in keeping or even raising the temperature following congenital heart surgery.

Afterdrop after hypothermic cardiopulmonary bypass: the value of tympanic membrane temperature monitoring

OBJECTIVES

After weaning from cardiopulmonary bypass (CPB), a decrease in nasopharyngeal temperature (NPT) occurs (afterdrop). The pathophysiology of the afterdrop remains unclear: It might be caused by either inadequate total body rewarming on CPB or to heterogenous distribution of heat during CPB, with subsequent redistribution of heat from the warmer core to the cooler shell tissues. The study objectives were (1) to determine whether post-CPB afterdrop is the result of a negative CPB thermal balance, and (2) to investigate which sites (if any) could best predict the afterdrop.

DESIGN

Prospective evaluation using within-patient comparisons during CPB cooling, CPB rewarming, and 45 minutes post-CPB.

SETTING

Adult patients gave informed consent before a cardiac surgical procedure in a university hospital.

PARTICIPANTS

Eight patients undergoing CABG or valvular replacement with hypothermic CPB (NPT near 29 degrees C) and standardized general anesthesia.

INTERVENTIONS

Each patient was studied with temperature monitors (Mon-a-therm 7000; Mallinckrodt-Medexel, Gemenos, France) attached to disposable thermocouple probes placed as follows: urinary bladder, rectum, deltoid, esophagus, nasopharynx, tympanic membrane, and four skin sites. In addition, the temperatures from the thermistors of the pulmonary artery catheter, and the arterial and venous lines of the CPB circuit were considered. Thirteen sites for monitoring temperature were studied.

MEASUREMENTS AND MAIN RESULTS

Temperatures were recorded every 5 minutes, from the beginning of CPB to the 45th minute after CPB, and thermal exchanges were calculated: change in body heat (QBH), thermal exchanges between the patient and the pump (QCPB), metabolic heat production (Qm) (equal to calculated VO2 at the pump level), and heat loss to the environment (QS) (equal to QBH-QCPB-Qm). Thermal exchanges were obtained in six patients during the plateaus of cooling and rewarming, during the whole CPB phase, and after CPB. It was found that despite a change in QBH during rewarming (1,017 +/- 88 kJ) that was slightly greater than during cooling (-1,008 +/- 104 kJ) (mean +/- SEM), a significant decrease in post-CPB "core" temperature occurred (afterdrop: -1.4 degrees C). Magnitude of the afterdrop was directly related to the magnitude of tympanic membrane cooling and was negatively correlated to the temperature difference between the warmest site (tympanic membrane) and the coolest site (cutaneous thigh temperature) observed at the end of rewarming (r = -0.667; p < 0.05).

CONCLUSIONS

It is suggested that besides post-CPB heat loss, redistribution of heat may be involved in the mechanism of the afterdrop and that measurements of tympanic membrane and cutaneous thigh temperatures are the best monitors of adequacy of rewarming during CPB.

The benefits of active rewarming after cardiac operations: a randomized prospective trial

We conducted a prospective, randomized trial of three methods of rewarming patients after hypothermic cardiopulmonary bypass. Patients underwent either coronary artery bypass grafting or first-time valve replacement and were cooled to 32 degrees C during bypass. No significant differences existed among the groups as regards operative or preoperative parameters including hemodynamics and blood use. The patients actively warmed with a convective (Bair Hugger system, 3 hours) or a conductive blanket (electric overblanket, 4 hours) reached normothermia more quickly than those warmed with the space blanket (7 hours). This was reflected in significantly earlier extubation in the former two groups: Bair Hugger system 10.8 +/- 0.6 hours, electric blanket 11.3 +/- 1.0 hours, and space blanket 14.8 +/- 0.8 hours. Patients warmed with the space blanket required a higher dosage of morphine over the first 12 hours than those warmed with the electric blanket (10.4 vs 6.5 mg; p = 0.004), which may account for some of the differences between these two groups. No differences could be demonstrated between the two active blankets. On economic grounds we therefore recommend the reusable electric blanket for routine use.

The management of temperature during hypothermic cardiopulmonary bypass: II--Effect of prolonged hypothermia

In animals mild hypothermia (32-35 degrees C) reduces ischaemic brain injury, but this has not been investigated in humans. During hypothermic cardiopulmonary bypass (CPB) patients are made hypothermic (usually to 30-32 degrees C) but are then rewarmed at a time when they are still at risk of ischaemic brain injury. We investigated the feasibility and safety of maintaining mild hypothermia throughout the CPB period. Thirty adult cardiac surgical patients were randomized to either rewarming to 36-37 degrees C or to maintaining temperature at 34 degrees C without rewarming. On arrival in the recovery room, patients in the hypothermic group had a mean bladder temperature of 33.8 +/- 0.45 degrees C compared with 35.4 +/- 0.58 degrees C (mean +/- SD, P < 0.05) in the rewarmed patients. There were no differences between groups in intra- or postoperative blood loss or blood use, inotrope use, dysrhythmias, or myocardial infarction. The hypothermic group received more muscle relaxant for the treatment of shivering postoperatively. Our results suggest that mild hypothermia following CPB did not increase morbidity although larger studies are needed for confirmation.

The management of temperature during cardiopulmonary bypass: effect on neuropsychological outcome

Laboratory studies demonstrate that mild degrees of brain cooling (2 degrees C to 5 degrees C) confer substantial protection from ischemic brain injury, and that mild elevation of brain temperature can be markedly deleterious. During hypothermic cardiopulmonary bypass (CPB) patients are made hypothermic and then rewarmed at a time when they are exposed to neurological insults. Our studies show that during rewarming, peak brain temperatures near 39 degrees C often are achieved inadvertently. We hypothesize that maintaining brain temperature < or = 34 degrees C during and after CPB will reduce the incidence of postoperative neuropsychological deficits. We present safety data from a study of 30 patients assigned either to conventional hypothermic CPB with rewarming or a protocol where brain temperature is raised only to 34 degrees C at the time of separation from CPB. There was no difference in bleeding, cardiac morbidity, or time to extubation between groups. We designed a neuropsychological test battery to detect postoperative neuropsychological deficits and tested its usefulness in a preliminary sample of 15 patients undergoing hypothermic CPB. We found patient acceptability and compliance were good. Sensitivity also seemed adequate in that 30% of patients were identified as having deteriorated at 1 week postoperatively compared to preoperatively, a result similar to that reported by others. Clinical trials of the efficacy of mild hypothermia in modulating brain injury in humans are needed before techniques of CPB can be designed to optimize neuroprotection.

Comparison of vecuronium and meperidine on the clinical and metabolic effects of shivering after hypothermic cardiopulmonary bypass

The use of vecuronium and meperidine on the clinical and metabolic effects of shivering in mechanically ventilated patients after hypothermic cardiopulmonary bypass (CPB) was compared. Twenty adult male patients undergoing cardiac surgery were randomized to meperidine, 25 to 75 mg (n = 10), or vecuronium, 0.1 microgram/kg (n = 10), for the treatment of shivering during postoperative rewarming. Vecuronium was continued as an infusion at 1.0 microgram/kg/min for 4 hours. Meperidine abolished shivering in 50% of patients with a 60% recurrence within 2 hours and did not correct acute respiratory acidosis when it occurred. Vecuronium uniformly abolished shivering, corrected acute respiratory acidosis, and improved mixed venous oxygen saturation (20% v 4%), decreased oxygen consumption (-32% v -7%) and decreased end-tidal carbon dioxide (-21% v -5%) significantly more than meperidine (p < 0.005). Meperidine administration caused a significant decline in systolic blood pressure (121.9 +/- 10.6 mmHg to 106.9 +/- 8.5 mmHg, p = < 0.02). The authors conclude that, during rewarming after hypothermic CPB, muscle relaxation with vecuronium reverses both the clinical and metabolic effects of shivering more reliably and effectively than repeated boluses of meperidine, and with greater hemodynamic stability. Control can be maintained by continuous infusion of vecuronium with concomitant sedation for up to 4 hours without prolonging intubation time.

Differences in temperature changes between pediatric and adult patients after cardiopulmonary bypass

Nasopharyngeal (NPT) and rectal (RT) temperatures were continuously monitored in 51 adult or pediatric patients undergoing cardiac surgical procedures until 1 hour after the termination of cardiopulmonary bypass (CPB). The measurement also included the lowest NPT achieved and the dwelling time at that temperature on CPB, the rewarming time, the time on CPB, and the time that the chest remained opened after CPB. After the termination of CPB, the decrease of NPT (afterdrop) was significantly greater in the adult group than in the pediatric group. The mean decrease in adult patients was 1.34 +/- 0.65 degrees C versus 0.63 +/- 0.8 degrees C in pediatric patients. The combination of the NPT at the end of bypass (EndNPT), body weight times the EndNPT, and the dwelling of the lowest temperature times the EndNPT could predict 45% of the afterdrop. It is concluded that afterdrop occurs to a lesser degree in pediatric patients than in adults. This may be due to more efficient supplying of external heat to pediatric patients in whom there is a larger body surface area to weight ratio.

Comparison of meperidine and pancuronium for the treatment of shivering after cardiac surgery

Shivering after cardiac surgery can produce adverse haemodynamic and metabolic sequelae. In this study, the metabolic effects of shivering and the efficacy of treatment with meperidine or pancuronium were studied, using a metabolic cart, in 61 patients who had undergone cardiac surgery. The patients received premedication with morphine, perphenazine and diazepam or lorazepam, and were anaesthetised with fentanyl or sufentanil and diazepam. Muscle relaxation was achieved with pancuronium. Patients were monitored with a radial arterial line, pulmonary artery catheter and oesophageal and urinary bladder temperature probes. Rewarming to an oesophageal temperature of 38 degrees C was achieved before the termination of CPB and was maintained for a minimum of 15 min reperfusion time. Every 15 min after surgery, the patients' temperature at three sites (pulmonary artery, oesophagus, bladder) and shivering scores were monitored. Hourly measurements were made of haemodynamic variables (MAP, PAOP, CVP, SVR, PVR, CI), carbon dioxide production, oxygen consumption and respiratory quotient. If the patient shivered, the measurements were recorded prior to drug treatment and repeated 30 min later following randomization to either: meperidine 0.25 mg.kg-1 (Group 1), meperidine 0.5 mg.kg-1 (Group 2) or pancuronium 0.06 mg.kg-1 intravenously (Group 3). Thirty-two patients shivered and mean VO2 and VCO2 values were greater in the shivering group than in the nonshivering patients (VO2 334.8 +/- 17.6 vs. 240.5 +/- 8.8 ml.min-1; VCO2 238.8 +/- 17.2 vs 199.2 +/- 8.4 ml.min-1, P = 0.0001).(ABSTRACT TRUNCATED AT 250 WORDS)

A comparison of patient rewarming devices after cardiac surgery

Three regimens for rewarming patients after cardiac surgery involving hypothermic cardiopulmonary bypass were studied in 30 patients. The control group (n = 10) received no active rewarming, the oesophageal group (n = 10) was warmed centrally using an oesophageal heat exchanger and the radiant group (n = 10) was warmed peripherally with an overhead radiant heater. There were no statistically significant differences between the groups apart from the higher mean skin temperatures in the peripheral group.